Literature DB >> 29578513

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis.

Filippo Locri1, Monica Aronsson1, Ophélie Beaujean1, Anders Kvanta1, Helder André2.   

Abstract

We describe a model of puncture-induced iris neovascularization as a general model for noninvasive evaluation of angiogenesis. The model is also relevant for targeting neovascular glaucoma, a sight-threatening complication of diabetic retinopathy. This method is based on the induction of iris vascular response by a series of self-sealing uveal punctures on BALB/c mice and takes advantage of the postpartum maturation of mouse ocular vasculature. Mouse pups undergo uveal punctures from postnatal day 12.5, when the pups naturally open their eyes, until postnatal day 24.5. Due to the transparency of the cornea, iris vasculature can be analyzed easily through time by noninvasive in vivo methods. Furthermore, the semitransparent iris of BALB/c mice can be flatmounted for detailed immunohistologic analysis with minimal non-specific background staining. In this model, angiogenesis is mainly driven by the inflammatory and plasminogen activating systems. The puncture-induced model is the first to induce iris neovascularization in small rodents, and has the advantage of allowing direct noninvasive in vivo analysis of the angiogenic process. Moreover, the model can be combined with angiogenic modulating substances, which highlights its potential in the study of angiogenesis with an in vivo perspective.

Entities:  

Mesh:

Year:  2018        PMID: 29578513      PMCID: PMC5931668          DOI: 10.3791/57398

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  20 in total

1.  An experimental model of ectropion uveae and iris neovascularization in the cat.

Authors:  L M Hjelmeland; M W Stewart; J Li; C A Toth; M S Burns; M B Landers
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-04       Impact factor: 4.799

Review 2.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 3.  Ocular neovascularization: basic mechanisms and therapeutic advances.

Authors:  Michael Dorrell; Hannele Uusitalo-Jarvinen; Edith Aguilar; Martin Friedlander
Journal:  Surv Ophthalmol       Date:  2007-01       Impact factor: 6.048

Review 4.  Regulation of angiogenesis: wound healing as a model.

Authors:  Sabine A Eming; Bent Brachvogel; Teresa Odorisio; Manuel Koch
Journal:  Prog Histochem Cytochem       Date:  2007-08-20

5.  Noninvasive high-resolution in vivo imaging of cell biology in the anterior chamber of the mouse eye.

Authors:  Stephan Speier; Daniel Nyqvist; Martin Köhler; Alejandro Caicedo; Ingo B Leibiger; Per-Olof Berggren
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

6.  Neovascularization of the iris: an experimental model in cats.

Authors:  E Stefansson; M B Landers; M L Wolbarsht; G K Klintworth
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-03       Impact factor: 4.799

Review 7.  VEGF-initiated angiogenesis and the uPA/uPAR system.

Authors:  Johannes M Breuss; Pavel Uhrin
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

8.  A novel in vivo model of puncture-induced iris neovascularization.

Authors:  Ophélie Beaujean; Filippo Locri; Monica Aronsson; Anders Kvanta; Helder André
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

9.  Gene Transfer of Prolyl Hydroxylase Domain 2 Inhibits Hypoxia-inducible Angiogenesis in a Model of Choroidal Neovascularization.

Authors:  Anna Takei; Malena Ekström; Parviz Mammadzada; Monica Aronsson; Ma Yu; Anders Kvanta; Helder André
Journal:  Sci Rep       Date:  2017-02-10       Impact factor: 4.379

10.  Ocular Angiogenesis.

Authors:  Juliana L Dreyfuss; Ricardo J Giordano; Caio V Regatieri
Journal:  J Ophthalmol       Date:  2015-09-28       Impact factor: 1.909

View more
  3 in total

Review 1.  The uPAR System as a Potential Therapeutic Target in the Diseased Eye.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Vincenzo Pavone; Mario De Rosa; Dario Rusciano; Paola Bagnoli
Journal:  Cells       Date:  2019-08-18       Impact factor: 6.600

2.  UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis.

Authors:  Filippo Locri; Massimo Dal Monte; Monica Aronsson; Maurizio Cammalleri; Mario De Rosa; Vincenzo Pavone; Anders Kvanta; Paola Bagnoli; Helder André
Journal:  J Mol Med (Berl)       Date:  2019-06-26       Impact factor: 4.599

3.  Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy.

Authors:  Filippo Locri; Noemi A Pesce; Monica Aronsson; Maurizio Cammalleri; Mario De Rosa; Vincenzo Pavone; Paola Bagnoli; Anders Kvanta; Massimo Dal Monte; Helder André
Journal:  J Mol Med (Berl)       Date:  2020-09-17       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.